CHD Chemicals Limited conducted a separate meeting of independent directors on March 31, 2026, as part of its corporate governance practices. The meeting was held at the company's corporate office located at Plot No. 331, Industrial Area, Phase II, Panchkula, and was convened to address several key governance matters.

Meeting Details and Agenda

The independent directors' meeting commenced at 3:00 PM and concluded at 4:55 PM on March 31, 2026. The session was specifically organized to fulfill regulatory requirements and enhance the company's governance framework through comprehensive board evaluation processes.

Key Areas of Review

The independent directors focused on three primary areas during their deliberations:

• Board Performance Evaluation: Review of the performance of non-independent directors and assessment of the board of directors as a whole
• Information Flow Assessment: Evaluation of the quality, quantity, and timeliness of information flow between company management and the board of directors
• Chairperson Performance Review: Assessment of the company's chairperson performance, incorporating feedback from both executive and non-executive directors

Regulatory Compliance

The company has informed the Bombay Stock Exchange about the meeting outcomes under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. CHD Chemicals Limited, with script code 539800 on BSE, maintains its registered office at Plot No. 45, Industrial Area, Phase I, Chandigarh, while operating from its corporate office in Panchkula.

The meeting represents the company's commitment to maintaining robust corporate governance standards and ensuring effective board oversight of management activities.

CHD Chemicals Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved these results during their meeting held on February 14, 2026.

Financial Performance for Q3 FY26

The company reported mixed financial performance for the third quarter of FY26. While revenue from operations showed improvement, the company continued to face profitability challenges.

Nine Months Performance Analysis

For the nine months ended December 31, 2025, CHD Chemicals reported revenue from operations of ₹339.08 lakhs compared to ₹372.06 lakhs in the corresponding period of the previous year, representing a decline of 8.87%. The company's net loss for the nine-month period stood at ₹27.70 lakhs compared to ₹25.37 lakhs in the previous year.

Expense Breakdown

The company's major expense components for Q3 FY26 included cost of material consumed at ₹297.71 lakhs, employee benefit expenses of ₹17.00 lakhs, and other expenses totaling ₹7.60 lakhs. Notably, the company reported a positive change in inventories of ₹183.21 lakhs, which helped offset some operational costs.

Earnings Per Share

The basic and diluted earnings per share for continuing operations stood at negative ₹0.04 for Q3 FY26, compared to negative ₹0.05 in the previous quarter. For the nine months ended December 31, 2025, the earnings per share was negative ₹0.25.

Regulatory Compliance

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. The statutory auditors conducted a limited review of the third quarter results. The company noted that segment reporting is not applicable as its activities fall within a single business segment.